India ▾

BSE HEALTHCARE TRI · Sectoral / Thematic· NAV-verified

SBI Healthcare Opportunities Fund

₹5,870 cr across 35 positions, as filed for 2026-09-30. Returns are the fund's AMFI growth-plan NAV; holdings and behavior come from its filed monthly portfolios.

Returns, against the category

Q2 FY27: +20% over 1 year against the median Sectoral / Thematic fund's +2%.

OverQuarter1 year3 years (ann.)5 years (ann.)
SBI Healthcare Opportunities Fund+3%+20%+22%+17%
Median Sectoral / Thematic fund−2%+2%+12%+11%

1-year return at each quarter-end since Q3 FY24:

+38%Q3 FY24+58%Q4 FY24+39%Q1 FY25+49%Q2 FY25+42%Q3 FY25+20%Q4 FY25+21%Q1 FY260%Q2 FY26−3%Q3 FY26+1%Q4 FY26+14%Q1 FY27+20%Q2 FY27

What moved the fund, last 12 filed months

Contribution = the fund's filed weight each month × that stock's price move in its own filings, in percentage points of NAV. Corporate-action months are left out.

Helped

Stock12 monthsLatest month
Acutaas Chemicals Ltd.+4.3 pp+0.2 pp
Laurus Labs Ltd.+2.9 pp+0.1 pp
Divi's Laboratories Ltd.+2.5 pp−0.2 pp
Aether Industries Ltd.+2.4 pp+0.0 pp
Sudeep Pharma Ltd.+1.5 pp−0.0 pp

Hurt

Stock12 monthsLatest month
Cohance Lifesciences Ltd.−1.9 pp−0.0 pp
Max Healthcare Institute Ltd.−1.3 pp−0.5 pp
Concord Biotech Ltd.−0.8 pp−0.1 pp
Jupiter Life Line Hospitals Ltd.−0.8 pp−0.4 pp
Abbott India Ltd.−0.7 pp+0.0 pp

Holdings, as filed for 2026-09-30

HoldingSector% of fundValueHeld forVs avg cost
Sun Pharmaceutical Industries LimitedHealthcare11.14%₹654 cr62 mo+38%
Divi's Laboratories LimitedHealthcare7.91%₹465 cr62 mo+86%
Acutaas Chemicals LimitedHealthcare5.03%₹295 cr18 mo+190%
Apollo Hospitals Enterprise LimitedHealthcare4.45%₹261 cr9 mo+15%
Torrent Pharmaceuticals LimitedHealthcare4.42%₹259 cr62 mo+55%
Cipla LimitedHealthcare4.40%₹258 cr5 mo-7%
Laurus LabsHealthcare4.05%₹238 cr38 mo+322%
Max Healthcare Institute LimitedHealthcare3.80%₹223 cr62 mo+36%
Aurobindo Pharma LimitedHealthcare3.42%₹201 cr7 mo+23%
Aster DM Healthcare LimitedHealthcare3.21%₹188 cr31 mo+46%
Gland Pharma LimitedHealthcare2.96%₹174 cr62 mo+57%
Sudeep Pharma LimitedHealthcare2.79%₹164 cr11 mo+85%
Anthem Biosciences LimitedHealthcare2.75%₹161 cr15 mo+19%
Sai LifeHealthcare2.60%₹152 cr9 mo+69%
CORONA Remedies LimitedHealthcare2.43%₹142 cr1 mo0%

Top 15 of 35 equity positions. "Vs avg cost" estimates the fund's gain on the position from its filing history.

How this fund actually behaves

Computed from every filed monthly portfolio (62 months of filings) by the research pipeline.

Holding patienceMedian months a position is held (25th–75th band)21 mo (9–35)
Win rate on exitsClosed positions sold above entry, and the payoff ratio (18 exits)72% · payoff 5.5×
Loser handlingCuts losers vs averages down, from 12 months of filingsAverages down
Entry valuation disciplineMedian P/E paid on entries over 36 months; share above 50×57× · 60% over 50×
Portfolio valuation todayWeighted P/E and P/B of the current book at filed prices101.1× P/E · 11.7× P/B
ChurnStocks entered and exited in 12 months, of 35 positions16 in · 11 out
ConcentrationTop 10 holdings' share; effective number of positions52% · ~22 effective